During the past decade, Harasanshin Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Harasanshin Hospital" #1 sponsor was "Celgene" with 1 trials, followed by "Eli Lilly and Company" with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored, "Otsuka Pharmaceutical Co., Ltd." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Harasanshin Hospital" are "Cardiac Edema (CHF)" (1 trials), "Chronic Myelogenous Leukemia" (1 trials), "Colitis, Ulcerative" (1 trials), "Heart Failure" (1 trials) and "Heart Failure With Preserved Ejection Fraction" (1 trials). Many other conditions were trialed in "Harasanshin Hospital" in a lesser frequency.

Most popular intervention types in "Harasanshin Hospital" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Desmopressin" (1 trials), "LY3540378" (1 trials), "OPC 131461 10mg group" (1 trials) and "OPC 131461 1mg group" (1 trials). Other intervention names were less common.

The vast majority of trials in "Harasanshin Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Harasanshin Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Harasanshin Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Harasanshin Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".